Trump Orders Fast-Track Review of Psychedelics, Ibogaine

April 19, 2026·about 2 hours ago·via Los Angeles Times

President Trump signs executive order to accelerate FDA review of psychedelics, spotlighting ibogaine for its potential in treating veteran PTSD and addiction. This bold move cuts through bureaucratic red tape that has stalled promising therapies for years, prioritizing American lives over big government's nanny-state control. Ibogaine, sourced from African roots, shows real promise in resetting brain chemistry for opioid recovery, yet faces controversy from risk-averse regulators. Read more about this...

Related Coverage

WebsiteTRUMP’S GENIUS GEOPOLITICAL MASTERSTROKE EXPOSED: Venezuela and Iran Aren’t Just “Oil Grabs” — They’re the Key to Containing China and Cementing 100 Years of Undisputed American Hegemony! — The Gateway Pundit

WebsiteFederal judge calls HHS Secretary Kennedy 'unserious,' complains of 'flouting of court orders' — Washington Times

SubstackDeal Undone. — News Items

WebsiteWATCH: FBI Director Kash Patel Says ‘Arrests Are Coming Soon’ for Deep State Coup Plotters Who Tried to Rig Elections Against Trump, ‘Comey Is Not the Only One’ — The Gateway Pundit

WebsiteUS Negotiators Head Back to Islamabad, but the Iranians May Not Be There — RedState

WebsiteVance says he's 'grateful' for Pope Leo's statement on not wanting public debate with Trump — Fox News Politics

WebsiteTrump wants to stop states from regulating AI. This Utah Republican isn't listening — Washington Times